Keith Bryant
Passionate about Patients
- Role
- Executive Director Business Development, Head of Outlicensing at Halozyme, Inc.
- Location
- San Diego, CA, US
- LinkedIn followers
- 500 followers
About Keith Bryant
MBA in Finance, NYU. Initially a Booz.Allen & Hamilton (NY) strategy consultant focused on big pharma, followed by 25 years in San Diego biotech across a very broad set of therapeutic areas and situations. Multiple BD deals from both sides of the table.
Experience
Executive Director Business Development, Head of Outlicensing
Jun 2023 — Present · San Diego, CA, US
Halozyme\'s commercially validated ENHANZE® drug delivery technology, based on our proprietary enzyme rHuPH20, is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids. When co-formulated with other drugs, ENHANZE® has the potential to reduce treatment burden for patients, including potentially reducing treatment administration from hours-long IV infusions to subcutaneous injections delivered in minutes. We have expanded our technology platform offering by adding a range of auto-injectors designed for subcutaneous and intramuscular use. With more than 30 years of experience in auto-injector device development and engineering, our internal development team specializes in creating custom designed drug delivery devices that address patient and therapeutic needs.
Education
NYU Stern School of Business
MBA, Finance
1994 — 1996
Yale University
Master of Music, Percussion
1987 — 1989
Texas Tech University
Bachelor of Arts (B.A.)
1983 — 1987
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.